Cargando…
Quantitative Research of (11)C-CFT and (18)F-FDG PET in Parkinson’s Disease: A Pilot Study With NeuroQ Software
Dopamine transporter (DAT) and glucose metabolism imaging have been applied in the diagnosis of Parkinson’s disease (PD). We explored the possibility of evaluating for PD with NeuroQ software by analyzing (11)C-2β-carbomethoxy-3β-(4-fluorophenyl) tropane ((11)C-CFT) and (18)F-FDG PET/CT. We retrospe...
Autores principales: | Sun, Xun, Liu, Fang, Liu, Qingyao, Gai, Yongkang, Ruan, Weiwei, Wimalarathne, Dilani Neranjana, Hu, Fan, Tan, Xubo, Lan, Xiaoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460224/ https://www.ncbi.nlm.nih.gov/pubmed/31024233 http://dx.doi.org/10.3389/fnins.2019.00299 |
Ejemplares similares
-
Impact of TOF on Brain PET With Short-Lived (11)C-Labeled Tracers Among Suspected Patients With AD/PD: Using Hybrid PET/MRI
por: Wimalarathne, D.D.N, et al.
Publicado: (2022) -
Evaluation of the diagnostic efficacy of (18)F‐Fluorine‐2‐Deoxy‐D‐Glucose PET/CT for lung cancer and pulmonary tuberculosis in a Tuberculosis‐endemic Country
por: Niyonkuru, Alexandre, et al.
Publicado: (2019) -
Optimized Application of (68)Ga-Prostate-Specific Membrane Antigen-617 Whole-Body PET/CT and Pelvic PET/MR in Prostate Cancer Initial Diagnosis and Staging
por: Qin, Chunxia, et al.
Publicado: (2021) -
pH-Triggered Assembly of Natural Melanin Nanoparticles for Enhanced PET Imaging
por: Liu, Qingyao, et al.
Publicado: (2020) -
(18)F-APN-1607 Tau Positron Emission Tomography Imaging for Evaluating Disease Progression in Alzheimer’s Disease
por: Xu, Xiaojun, et al.
Publicado: (2022)